Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-16 · accession 0001209191-23-024685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-18 | 2023-04-16 | RARE | Huizenga Theodore Alan | SVP, CAO | D - Sale to Iss | $38.20 | -181 | 27.5K | -0.7% | -$6,914 | |
| 2023-04-18 | 2023-04-16 | RARE | Huizenga Theodore Alan | SVP, CAO | F - Tax | $38.20 | -14 | 27.7K | -0.1% | -$534.80 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-16 | D | D | 181 | $38.20 | 27,520 | D | — | — | (F2) Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person (F3) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |
| 2 | Common | Common Stock | 2023-04-16 | F | D | 14 | $38.20 | 27,701 | D | — | — | (F1) Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). |